期刊文献+

于氏头针联合阿托伐他汀对中风危险因素的干预研究

下载PDF
导出
摘要 目的探讨于氏头针联合阿托伐他汀对中风危险因素高脂血症和高同型半胱氨酸血症的干预效果,以及预防脑卒中的价值。方法将80例研究对象随机分为观察组和对照组各40例,观察组采用于氏头针联合阿托伐他汀治疗,对照组采用阿托伐他汀治疗,比较二者的临床预防效果。结果两组研究对象与治疗前指标对比,差异有统计学意义(P〈0.05),观察组效果好于对照组(P〈0.05)。结论应用于氏头针联合阿托伐他汀对中风危险因素高脂血症和高同型半胱氨酸血症的临床治疗效果好,可以预防脑卒中的发生,值得临床推广应用。 Objective To explore the effect of the Yu's scalp acupuncture combined atovastatin on the risk factors for stroke of high blood lipid and hyperhomocysteinemia in serum, and the value of stroke prevention with the method. Methods 80 cases with high blood lipid and hyperhomocysteinemia were divided randomly into the investigation group (40 cases) and the control group (40 cases). The former took the Yu's scalp acupuncture combined atovastatin, the latter took the atovastatin, compared and observed theclinical efficacy of the two groups. Results Before and after treatment, compare two sets of data, significant difference ( P 〈0. 05 ), but the investigation group was better than the control group ( P 〈 0.05 ). Conclusion The Yu's scalp acupuncture combined atovastatin has a good clinical efficacy, in interfering the risk factors for stroke of high blood lipid and hyperhomocysteinemia, which can be effeetive in preventing stroke, and hence is worthy of being recommended in clinical practice.
作者 陶飞
出处 《浙江临床医学》 2010年第7期689-692,共4页 Zhejiang Clinical Medical Journal
关键词 中风 高血脂 高同型半胱氨酸血症 于氏头针 阿托伐他汀 Stroke High blood lipid Hyperhomocysteinemia Yu's scalp acupuncture Atovastatin
  • 相关文献

参考文献5

二级参考文献30

  • 1王永炎.中医内科学[M].上海:上海科学技术出版社,2000.132-136.
  • 2朱文锋 季绍良.中医病证治法术语[J].中医诊断学杂志,1997,(3):135-135.
  • 3Siess W,Zangl KJ,Essler M,et al.Lysophosphatidic acid mediates the rapid activation of platelets and endothehal cells by mildly oxidized low density lipoprotem and accumulates in human atherosclerotic lesions.Proc Natl Acad Sci U S A,1999,96(12):6931~6936
  • 4Gueguen G,Gaige B,Grevy JM,et al.Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.Biochemistry,1999,38(26):8440~8450
  • 5Baker RR,Chang HY.Evidence for two distinct lysophospholipase activities that degrade lysophosphatidylcholine and lysophosphatidic acid in neuronal nuclei of cerebral cortex.Biochim Biophys Acta,1999,1438(2):253~263
  • 6Siess W,Tigyi G Thrombogenic and atherogenic activities of lysophosphatidic acid.J Cell Biochem,2004,92(6):1086~1094
  • 7Rother E,Brandl R,Baker DL,et al.Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.Circulation,2003,108(6):741~747
  • 8Peterson JT,Li H,Dillon L,et al.Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.J.Cardiovase Res,2000,46(2):307~315
  • 9Zhang B,Ye S,Herrmann SM,et al.Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.Circulation,1999,99(14):1788~1794
  • 10Clausell N,Molossi S,Sett S,et al.h~ vivo blockade of minor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation.Circulation,1994,89(6):2768~2772

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部